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Background: The number of cells within mammalian
tissues is maintained by growth-stimulating and growth-
inhibiting mechanisms, with inhibitory signals being
superimposed over growth stimuli. This is reflected, in the
culture of normal adherent cells, by the phenomenon of
density-dependent inhibition of growth: cells cease prolif-
eration after becoming a confluent monolayer. We have
shown previously that a plasma membrane glycoprotein,
contactinhibin, is a major effector of negative growth reg-
ulation. Although transformed cells express contactinhibin
in a functionally active form, they are not growth-inhib-
ited, suggesting that the defects that lead to their aberrant
growth are located 'downstream' of contactinhibin.
Results: Here, we provide evidence that a 92 kD plasma
membrane protein, which we call CiR, binds specifically
to contactinhibin and acts as a receptor mediating the
contact-dependent inhibition of growth of cultured
human fibroblasts. When polyclonal antibodies against
CiR were introduced into cells using liposomes, conflu-
ent cells were released from density-dependent growth
control. By contrast, cross-linking CiR that is localized
to the plasma membrane, using anti-CiR antibodies, led
to growth inhibition, suggesting that CiR is a signalling
molecule and implicating CiR oligomerization in signal
generation. This conclusion is supported by the finding
that binding of contactinhibin by CiR is strongly depen-
dent on the local concentration of both molecules and has
a sharp threshold. When CiR was isolated by immuno-
precipitation under conditions favouring phosphory-
lation, it was hyperphosphorylated on serine and threo-
nine residues and had reduced contactinhibin-binding
capacity; the binding capacity of CiR was restored after
treatment with potato acid phosphatase. Fibroblasts trans-
formed with simian virus 40 had reduced CiR expres-
sion, higher CiR phosphorylation levels, and a strongly
reduced capacity of CiR to bind to contactinhibin. Phos-
phatase treatment of the CiR isolated from transformed
cells only partially restored its contactinhibin-binding
capacity.
Conclusions: Homeostasis is the net result of a highly
balanced network of growth-stimulating and growth-
inhibitory signals. We have shown that density-dependent
inhibition of growth in vitro is mediated by the interaction
of contactinhibin with a 92 kD plasma membrane glyco-
protein, CiR, the contactinhibin-binding capacity of
which is regulated by phosphorylation.
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Background
The growth of mammalian cells is under the balanced
control of positively and negatively acting factors. Al-
though a vast amount of information about mitogenic
factors and their receptors is available, not much is
known about their physiological antagonists. In order to
maintain tissue and organ size, one must postulate the
existence of growth-inhibiting signals reflecting the cel-
lular environment, the action of which would be super-
imposed over mitogenic signals. As the decision to cease
proliferation is determined largely by the cellular en-
vironment (for example, in wound healing or the need
for replacement of dead cells), negative growth control is
probably exerted by mechanisms initiated at the plasma
membrane. A good example of such negative growth
regulation is the density-dependent inhibition of growth
of mammalian cells in vitro. The most obvious explana-
tion for this phenomenon would be the interaction of
distinct cell membrane molecules that trigger growth-
inhibition after cell-cell contact. Although cell-cell
contacts attributable to defined classes of cell adhesion
molecules have clearly been shown to be involved in
processes such as determination and differentiation [1,2],
data on the molecular basis of density-dependent growth
regulation are scarce. Glycoproteins of the plasma mem-
brane have, however, been implicated in density-depen-
dent growth inhibition in many cell-culture systems [3-7].
We have found that a distinct plasma membrane glyco-
protein, referred to as contactinhibin, is responsible for
the density-dependent growth inhibition of normal hu-
man diploid fibroblasts [8]. Contactinhibin inhibits the
growth of cultured cells only in immobilized form, and
its activity is mediated exclusively by N-glycosidically
linked oligosaccharide side chains with terminal P3-glyco-
sidically linked galactose residues. Mouse fibroblasts
transformed with 3-methylcholanthrene lose contact-de-
pendent inhibition of growth as a result of losing respon-
siveness to contactinhibin [9], but contactinhibin itself is
expressed in biologically active form by these cells.
Because contactinhibin does not interact in a homophilic
fashion (our unpublished observations), these findings
suggest that there is a break in the signalling pathway of
transformed cells, affecting regulatory molecules other
than contactinhibin and leading to an escape from growth
control. We have therefore focussed on the identification
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of the plasma membrane component that specifically rec-
ognizes contactinhibin and triggers a negative growth
signal in response to contactinhibin binding. Here, we
describe the molecular and functional properties of this
candidate contactinhibin receptor isolated from human
diploid fibroblasts.
Results and discussion
Contactinhibin binds through its glycans to a 92 kD plasma
membrane protein
In a first approach, contactinhibin-binding proteins were
isolated by covalent binding of immobilized contactinhi-
bin to cell membrane proteins of cultured human FH109
fibroblasts, using the cleavable cross-linker 3,3'-dithiobis
(propionic acid)-N-succinimidester. The bound material
was separated by two-dimensional polyacrylamide gel
electrophoresis (Fig. 1) and was shown to contain a
92 kD component that had remarkable charge hetero-
geneity, which is probably due to variable degrees of
modification with the cross-linking agent. Other major
components that precipitated in the acidic region of the
isoelectric focusing gel resembled cytoskeletal proteins
(on the basis of their apparent molecular weights and
their relative cellular abundances) that could have been
co-isolated with the membrane proteins cross-linked to
contactinhibin (note that the sample was applied to the
basic end of the gel).
In order to detect contactinhibin-binding proteins in cell
extracts, a novel binding assay was developed (Fig. 2a).
This aggregation assay, based on the formation of rosettes
made up of immobilized contactinhibin and immobi-
lized cell-extract proteins, was used to isolate the contact-
inhibin receptor (CiR) and for preliminary studies of its
binding characteristics (see below). Figure 2b shows the
characteristic 'all-or-none' reaction between immobilized
contactinhibin and immobilized proteins from an extract
made with 8 mM CHAPS; the all-or-none phenomenon
was confirmed using an adhesion assay (see below). Simi-
lar binding-threshold effects are widespread, for example
in the aggregation of sponge cells [10], the adhesion of
hepatocytes to saccharide-coated surfaces [11], cell sort-
ing [12] or the regulation of neurite outgrowth [13].
After acetone precipitation, detergent-solubilized pro-
teins from FH109 fibroblasts were washed extensively
with distilled water to remove hydrophilic cytosolic pro-
teins, and thereafter separated by preparative SDS gel
electrophoresis. Slab gels were cut horizontally into strips
and the proteins electroeluted and tested for contactin-
hibin-binding activity. An 80-90 kD fraction had the
highest binding activity (Figs 3a,b). The next purifica-
tion step, preparative two-dimensional SDS gel electro-
phoresis, led to the isolation of a 92 kD contactinhibin-
binding protein that had charge microheterogeneity
(isoelectric point pH 5.9-6.6; Fig. 3c) and resembled the
92 kD component observed in the cross-linking experi-
ment. In addition to this 'p92', a more acidic, 90 kD pro-
tein was observed, but this had no contactinhibin-bind-
ing activity (data not shown). The microheterogeneity
of p92 can be explained by varying degrees of glycan
sialylation (Figs 4c,d) and protein phosphorylation (see
below; Fig. 7).
Further studies revealed that the growth-inhibitory activ-
ity of contactinhibin and its interaction with p92 - the
putative CiR - share common structural features (Table
1), supporting the conclusion that p92 is the contactin-
hibin-receptor; we refer to it henceforth as CiR. Both
are dependent upon the presence of terminal 3-glycosidi-
cally linked galactose residues on contactinhibin, both are
mediated by the N-linked glycans of contactinhibin; all
other glycoproteins tested, such as asialofetuin or asialo-
ol-acid glycoprotein, were without effect on proliferation
Fig. 1. Covalent cross-linking of contact-
inhibin to fibroblasts yields a 92 kD
protein. (a) Two-dimensional gel-elec-
trophoretic analysis (fluorography) of
total fibroblast proteins solubilized with
8 mM CHAPS, compared to (b) cross-
linked proteins. The migration of pro-
teins with known molecular weights is
indicated on the left, and the upper
scale shows the pH gradient after iso-
electric focusing. In addition to the
putative contactinhibin receptor, CiR(arrow), several other proteins, probably
representing cytoskeletal elements,
were found in the cross-linked material:
v, vimentin; at, a tubulin; Pt, 3 tubulin.
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Fig. 2. Aggregation assay. (a) Contactinhibin was coupled covalently to 'Fluoresbrite' beads (1 pgm in diameter), and CiR- bearing
fractions ('protein') were linked to silica beads (10 pAm in diameter). Co-incubation of the beads leads to rosette formation, which can
be visualized by fluorescence microscopy (insert). (b) Immobilized contactinhibin and immobilized proteins of an extract of human
fibroblasts made in 8 mM CHAPS were mixed and gently shaken for 30 min, and aggregation was then examined by microscopy.
Aggregation was scored as positive when a silica bead was covered with at least eight contactinhibin-coated microspheres and is
indicated as the percentage of total beads that were positive.
and did not bind to CiR. Furthermore, in agreement examined the effects on human fibroblast cultures of
with the finding that fluid-phase contactinhibin lacks polyclonal anti-CiR immunoglobulin G antibodies. The
growth-inhibitory activity, we observed that detergent- antibodies, raised in rabbits, specifically recognized p92
solubilized contactinhibin was not bound by CiR. on western immunoblots of detergent-extracted FH109
and SV40-transformed Wi38 fibroblasts (Fig. 4, lanes e
Growth inhibition by cross-linking cell-surface CiR using and f), and in immunoprecipitates of similar material
antibodies (Fig. 4, lane g). In the aggregation assay, these antibodies
To test the hypothesis that CiR generates a growth- fully inhibited the interaction between contactinhibin-
inhibitory signal after interaction with contactinhibin, we coated microspheres and silica beads coated with crude
Fig. 3. Purification of CiR. (a) SDS poly-
acrylamide gel electrophoresis of indi-
vidual fractions of FH109 proteins
obtained after preparative electrophor-
esis, and (b) the corresponding contact-
inhibin-binding activity as monitored
using the aggregation assay shown in
Fig. 2. (c) Two-dimensional SDS gel
electrophoresis of fraction 6 obtained
after preparative electrophoresis. The
position of CiR is indicated; purified CiR
was obtained by electroelution of the
relevant spots. The migration of proteins
with known molecular weights is indi-
cated on the right, and the upper scale
shows the pH gradient after isoelectric
focusing.
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signal-transducing receptor for contactinhibin in media-
ting density-dependent inhibition of growth.
Fig. 4. Characterization of CiR and anti-CiR antibodies. Lanes are
as follows. (a) 200 ng of CiR purified by two-dimensional SDS-
gel electrophoresis and silver stained. Detection of (b) glycan
moieties, (c) (x-2,3- and (d) ca-2,6-linked sialic acid residues on
1 ILg CiR. Western immunoblot using anti-CiR antibodies and
20 jlg protein in each of (e) FH109 fibroblasts and (f) SV40-
transformed Wi38 fibroblasts solubilized with CHAPS; (g) silver
stain of immunoprecipitated CiR (note that the protein migrating
with an approximate molecular weight of 43 kD is co-precipi-
tated actin, as assessed by immunoreactivity (data not shown).
(h) Western blot analysis of immunoprecipitated CiR . The faster-
migrating compound is a CiR degradation product, which is
observed variably both in extracts and in purified CiR prepara-
tions; compare also with Fig. 8a. All analyses were performed on
SDS polyacrylamide slab gels (7.5 %).
Intracellular capturing of CiR with anti-CiR-antibodies
releases cells from density-dependent growth inhibition
We have suggested that a growth-inhibitory signal is trans-
duced either by a direct action of CiR, or by the action
of proteins associated with CiR, after its interaction with
contactinhibin (as suggested above). Both effects should
be prevented by intracellular masking of CiR with anti-
CiR-antibodies, which should thus lead to growth stim-
ulation in confluent cell cultures. We therefore introduced
anti-CiR-antibodies into confluent FH109 fibroblasts
using cationic liposomes (made up of the lipid DOTAP;
see [15]). The efficiency of antibody-loading was moni-
tored by flow cytometry (Fig. 5f). A remarkable increase
in proliferation (up to 100 %) could be induced with
these antibodies in confluent cultures (Fig. 5d). This ef-
fect was probably due to a lack of responsiveness towards
the contactinhibin present on neighboring cells, as was
confirmed by the fact that growth was never affected
when cells loaded with anti-CiR antibodies were seeded
subconfluently (data not shown).
A further approach for studying the density-dependent
inhibition of growth involves the addition of glutaral-
dehyde-fixed cells to sparsely seeded cells [16]. Experi-
ments with sparsely seeded cells that received either a
four-fold or an eight-fold excess of glutaraldehyde-fixed
cells showed that cells loaded with anti-CiR antibodies
had strongly reduced responsiveness to the growth-
inhibitory signal provided by glutaraldehyde-fixed cells
detergent-extracted fibroblast proteins (Table 1). The ad-
dition of anti-CiR antibodies to sparsely seeded fibroblasts
had only marginal growth-inhibitory effects (Fig. 5b),
which could, however, be increased by cross-lihnking the
primary antibodies with secondary antibodies (Fig. 5b).
A similar growth-inhibitory activity of anti-CiR anti-
bodies on sparsely seeded cells was observed when the
antibodies were coupled covalently to silica beads before
addition (Fig. 5a). This indicates that oligomerization of
CiR is necessary, and sufficient, for the induction of
negative growth signals.
In agreement with this suggestion, cell growth was not
influenced by the addition of anti-CiR Fab antibody
fragments to sparsely seeded fibroblasts, suggesting that,
in this case, no signal is generated and excluding the pos-
sibility that the signal after antibody addition results from
an antibody-induced conformational change in CiR, as
has been observed in the case of the epidermal growth
factor (EGF) receptor and anti-EGF-receptor anti-
bodies [14]. Anti-CiR antibodies inhibited proliferation
of sparsely seeded fibroblasts by up to 40 % when coated
onto microtiter wells (Fig. 5c), suggesting that clustering
of CiR by surface-immobilized antibodies is more ef-
fective than cross-linking with secondary antibodies or
with antibodies immobilized onto bead surfaces. In sum-
mary, the results described above indicate that CiR is the
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(Fig. 5e). Together, these results provide evidence that it
is the contactinhibin-induced growth-inhibitory pathway
that is bypassed by the introduction of anti-CiR antibod-
ies into cultured cells.
The CiR-contactinhibin interaction occurs with a threshold
In order to measure the contactinhibin-binding capacity
of CiR, we established a novel adhesion assay that in-
volved the adsorption of immunoprecipitated CiR onto
microtiter wells and the addition of contactinhibin bound
to microspheres bearing an alkaline phosphatase reporter
enzyme. A threshold of contactinhibin binding was ob-
served (Fig. 6a, solid line). Together with the data ob-
tained using the aggregation assay, these results indicate
that the interaction between contactinhibin and CiR is
highly specific, but of low affinity - characteristics that
are common to receptor interactions with ligands which
are insoluble under physiological conditions, such as the
extracellular matrix component, fibronectin [17,18]. The
low affinity of contactinhibin-CiR binding is also dem-
onstrated in the adhesion assay by the decreased binding
of contactinhibin-coated spheres to adsorbed CiR at
above-optimal local concentrations (Fig. 6b). This effect
might result from reduced binding valencies per contact-
inhibin-coated sphere when CiR is adsorbed at high
concentration, in which case the beads would removed
during washing (Fig. 6b). Affinity was also low when too
little CiR was adsorbed.
CiR isolated in the presence of the protein-tyrosine phos-
phatase inhibitor, vanadate, had enhanced phosphory-
lation (Fig. 7) and strongly reduced contactinhibin-bin-
ding capacity (Fig. 6a, blue line), pointing to an inverse
correlation between CiR's phosphorylation and its con-
tactinhibin-binding activity. This was confirmed by treat-
ment of immunoprecipitated CiR that had been isolated
in the presence of vanadate with potato acid phosphatase;
this led to a recovery of maximal binding (Fig. 6a, broken
line). Despite these results with orthovanadate, phospho-
amino-acid analysis revealed that CiR is phosphorylated
on serine and threonine residues only, with no detectable
phosphorylation on tyrosine (Fig. 8b). The finding that
vanadate enhanced CiR phosphorylation, despite not
Fig. 5. Antibody-mediated CiR cross-linking results in growth-
inhibition. Relative proliferation rates of FH109 fibroblasts cul-
tured for 24 h in the presence of (a) anti-CiR antibodies coupled
to silica beads; (b) fluid-phase antibodies in the presence of anti-
rabbit antibodies; and (c) antibodies coated onto the microtiter
wells, as described in Materials and methods. Values are given as
percentages + SD, compared to control cells not treated with
antibodies. Liposome-mediated loading of anti-CiR antibodies
into fibroblasts; the relative proliferation rates of FH109 fibro-
blasts after introduction of anti-CiR antibodies as described in
Materials and methods: (d) 2 x 104 cells per well, (cells seeded
confluently), or (e) 5 x 10 3 cells per well, in the presence of a
four-fold or eight-fold excess of glutaraldehyde-fixed cells.
Values are given as percentages ± SD, compared to control cells
treated with anti-epoxide hydrolase antibodies. (f) Flow cytomet-
ric analysis, as described in Materials and methods, of liposome-
mediated antibody-loading of human fibroblasts; upper panel,
control cells; lower panel, antibody-loaded cells.
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Fig. 6. The contactinhibin-CiR interaction. (a) The indicated amounts of CiR immunoprecipitated from detergent extracts of FH109
fibroblasts was adsorbed onto the surface of microtiter wells and incubated with contactinhibin immobilized onto microspheres bear-
ing alkaline phosphatase as reporter enzyme; immunoprecipitation was in the presence (blue line) or absence (solid black line) of
orthovanadate, and one fraction of CiR immunoprecipitated in the presence of orthovanadate was then treated with potato acid phos-
phatase (broken line). Values are given as absorbance units at 405 nm as an indication of coloured product produced by the alkaline
phosphatase reporter. (b) Mechanisms of adhesion of contactinhibin bound to microspheres to adsorbed CiR. At low CiR concentra-
tions, multiple interactions between contactinhibin-coated spheres and CiR are not possible, and as a result of low binding avidity, the
beads are washed away. At optimal ratios of contactinhibin:CiR, multiple interactions are favoured and thus increased adhesion
strength is observed. At higher concentrations of CiR, as a result of the geometry of the assay, multiple interactions are hindered again,
and beads are again washed away.
being able to detect tyrosine phosphorylation of CiR,
suggests an as yet unknown, indirect, effect of vanadate.
It remains to be seen whether CiR phosphorylation at
a distinct serine and/or threonine residue results in a
conformational change followed by loss of affinity for the
ligand, or whether there is an additional impairment of
signal generation by CiR following phosphorylation. In
this context, it should be noted that treatment of human
diploid fibroblasts with tetradecanoyl phorbol acetate,
which is known to activate the threonine/serine protein
kinase, PKC [19], leads to a loss of contact-dependent
inhibition of growth [20]. Most intriguing is the working
hypothesis that CiR could .be a substrate for certain
oncogene products, such as the serine kinase Raf [21],
activation of which would lead to CiR over-phosphory-
lation and a loss of responsiveness of cells to contactinhi-
bin. In this context, the higher phosphorylation level and
reduced binding activity of CiR in SV40-transformed
fibroblasts is particularly noteworthy.
SV40-transformed fibroblasts have reduced CiR expression
and increased CiR phosphorylation
Western blot analysis of SV40-transformed human Wi38
lung fibroblasts showed that they contain less CiR than
non-transformed FH109 fibroblasts (Fig. 8a). The phos-
phorylation level of CiR was higher in the transformed
fibroblasts (Fig. 8a), but phosphoamino-acid analysis
yielded the same phosphorylation pattern of serine and
threonine residues as in the non-transformed fibroblasts
(Fig. 8b). In addition, the phosphorylation level of CiR
in SV40-transformed Wi38 fibroblasts was only margin-
ally influenced by vanadate (Fig. 8c). As well as a higher
Fig. 7. CiR is a phosphoprotein. CiR was immunoprecipitated, in
the presence (+ vanadate) or absence (- vanadate) of orthovana-
date, from lysates of cells metabolically labelled with 32P-ortho-
phosphate; it was then analyzed by two-dimensional gel
electrophoresis and visualized by autoradiography. Basic (B)
and acidic (A) ends of the isoelectric focusing gels, and the
migration in one dimension of proteins with known molecular
weights (M), are indicated. Note that for improved comparison,
both gel rods of the isoelectric focusing step were separated on
a single slab gel.
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Fig. 8. (a) SV40-transformed human
fibroblasts contain reduced amounts of
CiR but it is highly phosphorylated.
Equal numbers of 32 P-labelled cells
were lysed, CiR was immunoprecipi-
tated and separated by two-dimensional
gel electrophoresis and either processed
for western blotting with anti-CiR anti-
bodies (upper panels) or for autoradiog-
raphy (lower panels). (b) CiR contains
both phosphoserine and phospho-
threonine residues. Phosphoamino-acid
analyses of CiR from FH109 and Wi38
SV40 fibroblasts. Migration of the phos-
phoamino-acid standards is indicated
by circles (Pi, inorganic phosphate). (c)
CiR phosphorylation in SV40-trans-
formed fibroblasts is only marginally
influenced by vanadate. Autoradio-
graphy of CiR immunoprecipitated from
32P-labelled cells followed by two-
dimensional gel electrophoresis.
phosphorylation level, strongly reduced contactinhibin-
binding activity was observed in these cells, and binding
was only partially restored after phosphatase treatment
(Fig. 9). This makes it likely that there are additional
alterations to the CiR from transformed cells.
Conclusions
We suggest that contactinhibin signalling through the
contactinhibin receptor is essential for the maintenance
of controlled cell growth. The function of the contactin-
hibin receptor, and in particular its binding to contactin-
hibin, is modulated by phosphorylation. As CiR from
SV40-transformed fibroblasts has drastically reduced con-
tactinhibin-binding ability, impaired CiR function may
result in loss of growth control, which may eventually
lead to tumorigenesis.
Materials and methods
All buffer chemicals and salts were purchased from Roth (Karls-
ruhe, Germany); other chemicals and reagents were obtained
from Sigma (Deisenhofen, Germany) unless otherwise specified.
Fig. 9. CiR from transformed cells has strongly reduced contactin-
hibin-binding affinity, even after treatment with potato acid phos-
phatase (PAP). Experiments are analogous to those shown in Fig. 6.
White dots, before PAP treatment; grey dots, after PAP treatment.
Cell culture
FH109 human diploid fibroblasts and Wi38 SV40-transformed
fibroblasts were cultured as described [16], except that CG
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medium (Vitromex, Vilshofen, Germany) supplemented with
0.5 % fetal calf serum was used instead of DMEM with 10 %
fetal calf serum.
Cross-linking experiments
FH109 fibroblasts were seeded onto 15 cm culture dishes at a
density of 1.5 x 104 cells cm -2 . The next day, medium was
exchanged for methionine-free DMEM (Biochrom/Seromed,
Berlin, Germany), and after 1 h, 925 kBq [35S]methionine
(53 TBq mmol-1; Amersham, Braunschweig, Germany) was
added for 24 h. Contactinhibin was coupled to derivatized
silica beads as described [22] and added to the cells. After
another 24 h in the incubator, the cells were washed three
times with phosphate buffered saline (PBS) and 10 ml 1 mM
3,3'-dithiobis(propionic acid)-N-succinimidester (Pierce, Rock-
ford, USA) in PBS + 10 % DMSO was poured onto the plate.
The dish was gently shaken for 30 min and washed with PBS,
cells were scraped from the dish with a 'rubber policeman' and
lysed with non-reducing SDS sample buffer (50 mM Tris-
HCI, pH 6.8, 5 % SDS, 10 % saccharose). Silica beads were
collected by centrifugation and washed with non-reducing
SDS sample buffer, then covalently bound material was eluted
by cleavage of the disulfide bond in the cross-linker with
50 mM dithiothreitol in sample buffer. Proteins in the eluate




propanesulfonate (CHAPS) was used to solubilize membrane
proteins for CiR isolation and aggregation studies; 8 mM
CHAPS was found to be the most effective concentration for
solubilization of CiR in a binding-competition study using the
aggregation assay (data not shown). Cells cultured to conflu-
ence were washed three times with PBS, and membrane pro-
teins were solubilized on the culture dish with 8 mM CHAPS
in PBS containing protease inhibitors (0.3 pM aprotinin,
0.1 p.M soybean trypsin inhibitor, 0.4 mM iodoacetamide,
5 pM pepstatin, 60 p.M phenylmethylsulfonylfluoride (PMSF)
and 4 .M leupeptin; final concentrations). After incubation at
4 C for 30 min, the supernatant was centrifuged at 4 C for
10 min at 3 000 xg, to remove cell debris.
Isolation of CiR
Membrane proteins from 100 confluent FH109 fibroblast cul-
ture dishes (150 mm diameter) were solubilized with 8 mM
CHAPS as described, with PMSF as the protease inhibitor.
Proteins were precipitated at 4 °C overnight with four volumes
of ice-cold acetone, followed by centrifugation at 1 500 x g for
20 min at 4 C. The pellet was extensively washed with dis-
tilled water (40 ml), dissolved in Laemmli sample buffer [23]
and heated for 10 min to 96 C. Proteins were separated by
preparative SDS-gel electrophoresis (7.5 % acrylamide gels) and
stained with Coomassie blue. The slab gels were sectioned hor-
izontally into eight slab strips and the proteins were electro-
eluted using a device from Biometra (Cologne, Germany);
100 pxg of each fraction was precipitated by chloroform/
methanol according to [24], and the pellet redissolved in 50 pIl
denaturation buffer (6 M urea, 0.01 M -mercaptoethanol in
0.01 M Tris-acetate, pH 7.8). The solution was diluted with
10 volumes of renaturation buffer (8 mM CHAPS in PBS,
0.02 % sodium azide) and dialyzed three times against 1 000
volumes of renaturation buffer at 4 C overnight.
Each fraction was tested for contactinhibin-binding in the
aggregation assay. The 80-90 kD fraction was subjected to
preparative two-dimensional electrophoresis and resolved into
two fractions, which were then rescreened for contactinhibin-
binding in the aggregation assay. Only the basic fraction
(pl 5.9-6.6) had contactinhibin-binding activity. Purified CiR
was obtained by electroelution of the relevant spots. Using the
described purification scheme, approximately 2 Rpg purified CiR
was obtained from 100 mg fibroblast proteins solubilized with
8 mM CHAPS, corresponding to approximately 1 x 108 cells.
Native CiR was isolated by immunoaffinity chromatography;
1 mg anti-CiR IgG antibody was coupled to 2 ml cyanogen
bromide-activated sepharose (Sigma) in a total volume of
6 ml buffer, according to the manufacturer's instructions. Cells
(5 x 106) were extracted with 4 ml CHMN (8 mM CHAPS in
20 mM HEPES, 1 mM MgCI 2, 0.5 M NaCI) for 15 min on ice
and precleared by 10 min centrifugation at 3 000 x g; the
resulting supernatant was incubated with the gel slurry at 4 °C
overnight. The gel was then packed into a small column and
washed with CHMN until no proteins could be traced in the
eluate by photometric detection at 280 nm. CiR was eluted
with 6 ml 0.1 M diethylamine, pH 11.6; 0.9 ml fractions were
collected and immediately neutralized with 0.1 ml 1 M Tris-
HCI, pH 7.0. Approximately 4 ng CiR was obtained from
1 x 106 FH109 fibroblasts.
Aggregation assay
Contactinhibin (10 pxg) dissolved in 15 RI1 coupling buffer
(0.1 M sodium carbonate, pH 9.0) containing 0.1 % SDS was
added to 500 l1 suspension of 'Fluoresbrite' polyacrolein
microspheres (Polysciences, Eppelheim, Germany; 2.5 % solids;
1 m diameter) that had been prewashed three times with
coupling buffer; 50 al1 0.1 M sodium cyanogen borohydride
(Merck, Darmstadt, Germany) solution was added immediately
and the suspension was shaken gently overnight. Afterwards,
the remaining reactive aldehyde groups were blocked with
0.2 M glycine, pH 8.0, and imino groups were again reduced
with sodium cyanogen borohydride overnight. After washing
with PBS, microspheres were stored at 4 °C in PBS containing
0.02 % sodium azide. The CiR-containing fractions were cou-
pled covalently to isothiocyanatopropyltriethoxysilane deriva-
tized silica beads (50 p.g protein coupled to 100 Ixl of 1.5 %
(w/v) suspension of silica beads) as described [22].
Aggregation was carried out as follows: 50 al1 beads attached to
fractions to be tested for contactinhibin-binding activity was
added to 2 l1 contactinhibin microspheres in 400 pl1 aggrega-
tion buffer (8 mM CHAPS in PBS containing 0.1 mg ml-1
bovine serum albumin (BSA) and 0.02 % sodium azide). The
beads were gently shaken on a rocker plate at room tempera-
ture for 30 min and aggregation was assessed by microscopy.
Aggregation was scored positive when a silica bead was cov-
ered with at least eight microspheres, and was defined as the
percentage of positive beads out of 100 total beads. Under
control conditions, binding of blank microspheres to silica
beads was < 2 %.
Adhesion assay
The contactinhibin-coated microspheres were prepared as
described, except that a second coupling step with bovine
intestine alkaline phosphatase (2.57 U mg-1 ) was introduced
using the glutaraldehyde method. The microspheres were
washed three times with 50 mM sodium phosphate, pH 6.8,
and resuspended in 5 l of this buffer containing 20 g bovine
intestine alkaline phosphatase; 50 Rl 1 % glutaraldehyde solu-
tion in PBS was added under vigorous stirring. Coupling was
stopped after 20 h at 4 C with 100 p 1 M ethanolamine,
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pH 7.0. After 2 h blocking, microspheres were washed three
times with PBS; 100 p,1 native CiR fractions, isolated with the
anti-CiR IgG column, were added to wells of a high-binding-
capacity ELISA plate (Nunc, Dreiech, Germany) in triplicate,
at several dilutions. After overnight incubation at 4 C, wells
were washed three times and blocked with 3 % BSA in PBS
containing 0.02 % sodium azide for 4 h. Each well received
2 Cpl contactinhibin-coated microsphere suspension. Micro-
spheres were allowed to settle and bind overnight at 4 C, and
non-bound microspheres were removed by carefully washing
with blocking buffer four or five times. The wells were then
washed with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl and
filled with 200 p,1 10 mM para-nitrophenylphosphate in 1 M
diethanolamine-HC1, pH 9.5. Color development was evalu-
ated in an ELISA reader (InterMed, Wiesbaden, Germany) at
405 nm after 24 h.
Anti-CiR antibodies
CiR separated by preparative two-dimensional gel electro-
phoresis as described was electroblotted onto nitrocellulose,
briefly stained with Coomassie brilliant blue, and the spots cor-
responding to CiR cut out. The nitrocellulose was dissolved in
DMSO and antibodies were generated by immunization of
white New Zealand rabbits. A total of eight boosts were per-
formed with incomplete Freund's adjuvant at three-week
intervals. The titer was determined to be > 20 000 by an
ELISA assay with purified CiR adsorbed onto the well surface.
Immunoprecipitation
Cells (5 x 106) were trypsinized, washed with PBS and
extracted with 500 Ixl solubilization buffer (50 mM HEPES-
NaOH, pH 7.5, 10 mM MgCl 2, 2 mM MnC12, 0.1 mM
EDTA, 0.4 mM EGTA, 0.5 mM dithiothreitol (DTT),
2.5 mM NaF and 1 % Nonidet P-40 (NP-40), containing the
protease inhibitors listed above) for 20 min on ice. Lysates
were cleared by centrifugation (12 000 x g, 10 min). CiR was
immunoprecipitated with rabbit polyclonal anti-CiR antibod-
ies coupled covalently to protein A sepharose, as described
[25], for 2 h at room temperature. Immunoprecipitates were
washed three times with 500 ,al solubilization buffer, once
with 500 p1l TNL buffer (50 mM Tris-HCl, 0.15 M NaCl,
10 mM EDTA, 0.5 mM LiCl, 0.5 % NP-40, pH 7.4), fol-
lowed by high and low salt buffer (0.1 or 0.01 M Tris-HC1,
pH 7.4) and bound material was eluted with 100 pil 0.1 M
diethylamine, pH 11.6. Eluates were precipitated with chloro-
form/methanol and aliquots loaded onto SDS-polyacrylamide
slab gels (7.5 %) or onto isoelectric focusing rod gels.
Treatment of CiR with potato acid phosphatase
CiR immunoprecipitated from 5 x 106 cells in the presence of
orthovanadate was resuspended in 20 p.1 40 mM PIPES, 1 mM
dithiotreitol, 20 ptg ml-l aprotinin, 20 IpM leupetin, pH 6.0,
and treated with 1.2 U potato acid phosphatase at 37 °C for
1 h [26]. Controls were mock-treated without enzyme. After
digestion, CiR was assessed in the adhesion assay for contactin-
hibin-binding activity, or, in the case of 32P-labelled CiR, ana-
lyzed by two-dimensional gel electrophoresis, followed by
autoradiographic visualization of CiR.
Western immunoblotting
Proteins separated by SDS-gel electrophoresis were elec-
troblotted overnight onto PVDF membranes (Millipore, Ger-
many) and blocked with 3 % BSA in TBS (50 mM Tris-HC1,
0.15 M NaCl, pH 7.5) containing 0.1 % Tween-20 (TTBS)
for 1 h. The membrane was incubated with anti-CiR poly-
clonal antiserum in 1:5 000 dilution in TTBS plus 3 % BSA for
1.5 h, and after three quick and three 10 min washes with
TTBS, incubated with alkaline phosphatase-conjugated goat
anti-rabbit IgG in 1:30 000 dilution for 1.5 h. After a final
short washing step in TBS, color was developed with 4.6 mM
4-nitroblue tetrazolium chloride and 4.3 mM 5-bromo-4-
chloro-3-indolylphosphate in 0.1 M Tris-HCl, pH 9.5, 0.1 M
NaCl, 5 mM MgCl 2.
The glycan chains of CiR electroblotted onto PVDF after
SDS-gel electrophoresis were detected with the Glycan Detec-
tion Kit (Boehringer Mannheim, Mannheim, Germany) accor-
ding to the manufacturer's instructions; oa-2,3- and ao-2,6-
linked neuraminic acid was detected with Maackia amurensis
(MAA) digoxigenated lectin and Sambucus nigra (SNA) digoxi-
genated lectin (both from Boehringer Mannheim, Mannheim,
Germany), respectively, with the same kit. Fetuin was used as a
positive control in all three cases.
Proliferation assays
The basic assay was as follows: 5 x 103 FH109 fibroblasts were
seeded per microtiter well in DMEM containing 0.5 % FCS.
After 24 h, reagents were added according to the schemes listed
below, and after a further 24 h culture period, cells were given
0.25 pCi [3 H]thymidine (NEN, Dreieich, Germany) and cul-
tured for an additional 4 h. Cultures were processed for
measurement of incorporated radioactivity as described [27].
The following schemes were used:
1. Anti-CiR IgG antibody was coupled to silica beads as
described [22]; 100 pLl bead suspension in DMEM containing
5 % FCS was added to wells.
2. Anti-CiR IgG was added to a final concentration of
25 Lg ml-', and after 30 min, goat anti-rabbit IgG was added to
a final concentration of 80 pxg ml-1 in DMEM plus 5 % FCS.
3. Microtiter wells were precoated overnight at 4 °C with
50 l1 per well 1 mg ml- l anti-CiR IgG before seeding fibrob-
lasts in CG medium containing 5 % FCS. After 24 h culture,
cells were given 0.25 IpCi [3 H]thymidine (NEN, Dreieich,
Germany) and cultured for an additional 4 h.
4. Anti-CiR IgG was introduced into cells with N-1-(2,3-
dioleoyloxy)propyl-N,N,N-trimethyl-ammonium methyl-
sulfate (DOTAP, Boehringer Mannheim, Germany) as follows.
FH109 fibroblasts were trypsinized and washed as described
[28]; 15 p.1 DOTAP (1 mg ml- in distilled water) and 35 p1
20 mM HEPES, pH 7.4, were mixed with 200 p1 IgG solution
(1 mg ml-1 in PBS) for 15 min at room temperature and added
to 1 x 106 fibroblasts in 1 ml CG medium containing 0.5 %
FCS. After 15 min in a 37 "C water bath, 9 ml CG medium
containing 5 % FCS was added and cells were collected by
centrifugation for 10 min at 800 x g. Cells were resuspended in
1 ml CG medium (0.5 % FCS), seeded into microtiter wells
and proliferation determined as described.
5. Glutaraldehyde-fixed cells were,prepared as described in
[9] and added in CG plus 5 % FCS to the cells 24 h after seed-
ing. Proliferation was determined as described.
Metabolic phosphate labelling and phosphoamino-acid
analysis
Fibroblasts (1 x 106 ) were seeded onto 9 cm petri dishes in
CG medium containing 5 % FCS and cultured for 3 days.
Cells were washed three times with phosphate-free medium
(110 mM NaCl, 5 mM KCI, 1.8 mM CaC12, 0.8 mM MgC1 2,
30 mM NaHCO 3, 23 mM D-glucose, 15 mM HEPES,
1 mg ml-t BSA) and starved for 3 h; 300 tpCi [32 P]orthophos-
phate (338 TBq mmol-1, NEN) was added per ml medium.
After 2 h, cells were washed four times with phosphate-free
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medium and lysed in 1 ml solubilization buffer, followed by
CiR immunoprecipitation as described above; the last two
washing steps were omitted. Probes were separated by two-
dimensional gel electrophoresis, the gels dried and autoradio-
graphed for 1 week. The relevant spots were cut out, subjected
to protein hydrolysis and analyzed with a Hunter Thin Layer
Electrophoresis System (C.B.S. Scientific Company, Del Mar,
USA) according to the manufacturer's instructions. Fluorographs
were developed after 20 days.
Preparation of contactinhibin glycopeptides
Contactinhibin (5 pxg) dissolved in 50 1 TC buffer (0.1 M
Tris-HCI, pH 8.0, 1 mM CaCI 2) was digested with 1 mg
pronase that had previously been heated for 30 min to 65 C.
Digestion was performed for 72 h at 37 C with addition of
fresh pronase (1 mg) every 24 h. The enzyme was precipitated
by addition of ethanol (9:1, v/v) overnight at -20 C, followed
by centrifugation. The supernatant was vacuum-dried, dis-
solved in 50 I coupling buffer and, after buffer exchange
against coupling buffer over a P2 column (Biorad, Munich,
Germany) to remove residual Tris molecules, glycopeptides
were coupled to microspheres as described.
Treatment of contactinhibin-coated microspheres with
0-galactosidase
Contactinhibin-coated microspheres (5 pIl) were washed twice
with P-GI-buffer (0.1 M citric acid, 0.1 M NaHPO, 10 %
glycerol, 0.1% Triton X-100, pH 4.3) and incubated in
100 R1 -GI-buffer containing 0.5 U P-galactosidase from
bovine testis (Boehringer Mannheim, Mannheim, Germany)
at 37 C for 16 h. Control beads were treated the same way
but without enzyme.
Anti-contactinhibin-antibodies
Antibodies were generated as described [8].
Protein quantification
Protein quantification was performed according to [29], with
bovine serum albumin as a standard.
Gel electrophoresis
Two-dimensional polyacrylamide gel electrophoresis was
performed as described [30].
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